company background image
A019170 logo

Shinpoong PharmaceuticalLtd KOSE:A019170 Stock Report

Last Price

₩12.15k

Market Cap

₩637.8b

7D

-0.2%

1Y

-14.4%

Updated

09 Oct, 2024

Data

Company Financials

Shinpoong Pharmaceutical Co.,Ltd

KOSE:A019170 Stock Report

Market Cap: ₩637.8b

A019170 Stock Overview

Manufactures and sells pharmaceutical products in South Korea.

A019170 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Shinpoong Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shinpoong PharmaceuticalLtd
Historical stock prices
Current Share Price₩12,150.00
52 Week High₩19,850.00
52 Week Low₩9,560.00
Beta0.81
11 Month Change-1.22%
3 Month Change1.76%
1 Year Change-14.38%
33 Year Change-79.09%
5 Year Change91.04%
Change since IPO539.34%

Recent News & Updates

Recent updates

Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Sep 11
Shinpoong Pharmaceutical Co.,Ltd's (KRX:019170) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Aug 08
Is Shinpoong PharmaceuticalLtd (KRX:019170) Weighed On By Its Debt Load?

Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Apr 24
Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Mar 07
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?

Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

Feb 01
Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?

We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Jan 05
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide

Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Dec 10
Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?

Shareholder Returns

A019170KR PharmaceuticalsKR Market
7D-0.2%1.7%0.3%
1Y-14.4%19.3%6.4%

Return vs Industry: A019170 underperformed the KR Pharmaceuticals industry which returned 19.3% over the past year.

Return vs Market: A019170 underperformed the KR Market which returned 6.4% over the past year.

Price Volatility

Is A019170's price volatile compared to industry and market?
A019170 volatility
A019170 Average Weekly Movement12.9%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement6.8%
10% most volatile stocks in KR Market12.0%
10% least volatile stocks in KR Market3.5%

Stable Share Price: A019170's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A019170's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1962828Jei-Man Ryushinpoong.co.kr

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.

Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary

How do Shinpoong PharmaceuticalLtd's earnings and revenue compare to its market cap?
A019170 fundamental statistics
Market cap₩637.77b
Earnings (TTM)-₩41.63b
Revenue (TTM)₩208.78b

3.0x

P/S Ratio

-15.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A019170 income statement (TTM)
Revenue₩208.78b
Cost of Revenue₩129.35b
Gross Profit₩79.43b
Other Expenses₩121.06b
Earnings-₩41.63b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-812.13
Gross Margin38.05%
Net Profit Margin-19.94%
Debt/Equity Ratio16.4%

How did A019170 perform over the long term?

See historical performance and comparison